April 7 (Reuters) - Insmed (INSM.O), opens new tab said on Tuesday it ‌would discontinue the development of its treatment for a chronic, inflammatory skin condition, after the drug failed a mid-stage ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A new study from Monash University reveals that adults with Attention-Deficit/Hyperactivity Disorder (ADHD) experience brief sleep-like brain activity during the day ...

A new study suggests a substance in python blood could lead to new weight loss therapies for humans. The mice given the substance lost 9% of their body weight over 28 days. Scientists believe this ...

CU Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The ...

Shield AI's Hivemind AI program piloted Anduril's YFQ-44A uncrewed aircraft for the first time. Hivemind was selected earlier to provide autonomy for the Air Force's drone wingmen. The Air Force ...

Sanofi has backed the $75 million series B of a rhinovirus-focused biotech with a former FDA acting commissioner at the helm. Altesa BioSciences unveiled back in 2022 with $4 million in seed funding ...

Pfizer (PFE) announced on Tuesday that a mid-stage trial evaluating a monthly maintenance dosing regimen of its experimental obesity drug indicated that the GLP-1 receptor agonist PF’3944 (MET-097i) ...

The lineup for Turning Point USA's "All-American Halftime Show" is finally here. The show, put on by the conservative organization to compete with Bad Bunny's Super Bowl halftime performance, will ...